TickerGuard
Buy Day today: Poor (42) Weak market breadth · today: Nonfarm Payrolls (October)
TMO

Thermo Fisher Scientific Inc

Healthcare · Diagnostics & Research

676.90$ -4.1% vs. previous close Closing price · As of: Nov 5, 2026

Statements

Income Statement

Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 44,557 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TMO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
16,890 16,965 18,274 20,918 24,358 25,542 32,218 39,211 44,915 42,857 42,879 44,557
9,004 9,127 9,692 11,239 13,370 14,198 16,191 19,577 25,904 25,295 25,151 26,318
7,886 7,838 8,582 9,679 10,988 11,344 16,027 19,634 19,011 17,562 17,728 18,239
691 692 755 888 967 1,003 1,181 1,406 1,471 1,337 1,390 1,397
4,896 4,612 4,976 5,492 6,057 6,144 6,930 6,842 7,127 8,612 8,595 7,272
5,537 5,344 5,723 6,412 7,116 7,085 8,130 9,316 10,486 10,703 10,066 10,129
2,348 2,495 2,859 3,267 3,872 4,259 7,897 10,318 8,525 6,859 7,662 8,109
480 415 470 592 667 676 553 536 726 1,375 1,654 1,419
2,087 1,936 2,024 2,429 3,262 4,070 7,227 8,837 7,663 6,298 6,995 7,267
192 -44 -1.4 201 324 374 850 1,109 703 -284 657 547
1,894 1,975 2,022 2,225 2,938 3,696 6,375 7,725 6,950 5,995 6,335 6,737
4,252 4,040 4,252 5,054 6,196 7,023 10,108 11,969 11,942 6,859 11,800 11,466

Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?